![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, December 08, 2009 4:46:00 PM
In reply to: garyhalvo who wrote msg# 6238 Post # of 6311
- On November 9th, Imaging 3 confirmed that they re-submitted to the FDA regarding the intended use label.
- FDA approvals are typically not sent via letter they are sent via fax similar to the confirmations that Dean has received from the FDA in the past. This fax will be coming from the Eastern time zone, therefore may arrive in the early AM.
- On the last conference call, I believe Dean stated that the FDA has 30 days to respond to their re-submission. 30 Days will be Wednesday, Dec 9th.
- Holding strong with shares at $0.035
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM